Immunotherapy combo eyed as Pre-Surgery option for rare eye cancer
Disease control
Recruiting now
This early-phase trial tests whether giving two immunotherapy drugs (nivolumab and ipilimumab) before eye removal surgery is safe and feasible for people with high-risk uveal melanoma, a rare eye cancer. Fifteen participants will receive the drugs, then have their eye removed. Th…
Phase: PHASE1 • Sponsor: Inge Marie Svane • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC